{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:01:37Z","timestamp":1789851697908,"version":"4.0.1"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100023581","name":"National Science Foundation Graduate Research Fellowship Program","doi-asserted-by":"publisher","award":["DGE1122492"],"award-info":[{"award-number":["DGE1122492"]}],"id":[{"id":"10.13039\/100023581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35-GM122485"],"award-info":[{"award-number":["R35-GM122485"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000997","name":"Arnold and Mabel Beckman Foundation","doi-asserted-by":"publisher","award":["17-001959"],"award-info":[{"award-number":["17-001959"]}],"id":[{"id":"10.13039\/100000997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001021","name":"Damon Runyon Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Structure"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.str.2026.08.013","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:48:49Z","timestamp":1789742929000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Modulating pseudokinase conformation from the ATP-binding site"],"prefix":"10.1016","author":[{"given":"Joshua B.","family":"Sheetz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Tsutsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar D.","family":"Ashtekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Mathea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3379-5319","authenticated-orcid":false,"given":"Mark A.","family":"Lemmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.str.2026.08.013_bib1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/s41573-021-00252-y","article-title":"Trends in kinase drug discovery: targets, indications and inhibitor design","volume":"20","author":"Attwood","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.str.2026.08.013_bib2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrd.2018.21","article-title":"Kinase inhibitors: the road ahead","volume":"17","author":"Ferguson","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.str.2026.08.013_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2016.230","article-title":"A comprehensive map of molecular drug targets","volume":"16","author":"Santos","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.str.2026.08.013_bib4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41573-021-00195-4","article-title":"Kinase drug discovery 20 years after imatinib: progress and future directions","volume":"20","author":"Cohen","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.str.2026.08.013_bib5","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/d41573-025-00188-7","article-title":"FDA approves 100th small-molecule kinase inhibitor","volume":"24","author":"Mullard","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.str.2026.08.013_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100705","article-title":"There\u2019s more to death than life: non-catalytic functions in kinase and pseudokinase signaling","volume":"296","author":"Mace","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.str.2026.08.013_bib7","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.tibs.2022.04.011","article-title":"Looking lively: emerging principles of pseudokinase signaling","volume":"47","author":"Sheetz","year":"2022","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.str.2026.08.013_bib8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.tcb.2006.07.003","article-title":"Emerging roles of pseudokinases","volume":"16","author":"Boudeau","year":"2006","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.str.2026.08.013_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaad.2022.08.061","article-title":"Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 program for evaluation of TYK2 inhibitor psoriasis second trial","volume":"88","author":"Strober","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.str.2026.08.013_bib10","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1021\/acs.jmedchem.9b00444","article-title":"Highly selective inhibition of tyrosine kinase 2 (TYK2) for the treatment of autoimmune diseases: Discovery of the allosteric inhibitor BMS-986165","volume":"62","author":"Wrobleski","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.str.2026.08.013_bib11","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.1075762","article-title":"The protein kinase complement of the human genome","volume":"298","author":"Manning","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.str.2026.08.013_bib12","first-page":"501","article-title":"Prospects for pharmacological targeting of pseudokinases","volume":"18","author":"Kung","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.str.2026.08.013_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1042\/BJ20131174","article-title":"A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties","volume":"457","author":"Murphy","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.str.2026.08.013_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.str.2015.10.020","article-title":"Structural basis for the non-catalytic functions of protein kinases","volume":"24","author":"Kung","year":"2016","journal-title":"Structure"},{"key":"10.1016\/j.str.2026.08.013_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1042\/BJ20141060","article-title":"Going for broke: targeting the human cancer pseudokinome","volume":"465","author":"Bailey","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.str.2026.08.013_bib16","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.sbi.2010.10.001","article-title":"Pseudokinases-remnants of evolution or key allosteric regulators?","volume":"20","author":"Zeqiraj","year":"2010","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.str.2026.08.013_bib17","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1042\/BCJ20220373","article-title":"Emerging functions of pseudoenzymes","volume":"480","author":"Goldberg","year":"2023","journal-title":"Biochem. J."},{"key":"10.1016\/j.str.2026.08.013_bib18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.tibs.2024.11.006","article-title":"Protein shapeshifting in necroptotic cell death signaling","volume":"50","author":"Hoblos","year":"2025","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.str.2026.08.013_bib19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/bs.mie.2022.03.039","article-title":"Conformational control and regulation of the pseudokinase KSR via small molecule binding interactions","volume":"667","author":"Chow","year":"2022","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.str.2026.08.013_bib20","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"Lemmon","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.str.2026.08.013_bib21","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.molcel.2020.06.018","article-title":"Structural insights into pseudokinase domains of receptor tyrosine kinases","volume":"79","author":"Sheetz","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.str.2026.08.013_bib22","doi-asserted-by":"crossref","first-page":"16138","DOI":"10.1021\/acs.jmedchem.5c01080","article-title":"Structure-based discovery of quinazolin-2-amine derivatives as potent ROR1 pseudokinase inhibitors with in vitro and in vivo efficacy against triple-negative breast cancer","volume":"68","author":"Lu","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.str.2026.08.013_bib23","doi-asserted-by":"crossref","first-page":"11188","DOI":"10.1021\/acs.jmedchem.5c00189","article-title":"Optimization of 1-methyl-3-(pyridin-3-yl)-1H-indol derivatives as ROR1 inhibitors with improved activity and selectivity","volume":"68","author":"Zheng","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.str.2026.08.013_bib24","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1021\/acschembio.1c00826","article-title":"Discovery of small-molecule inhibitors of the PTK7\/\u03b2-catenin interaction targeting the Wnt signaling pathway in colorectal cancer","volume":"17","author":"Ganier","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.str.2026.08.013_bib25","doi-asserted-by":"crossref","first-page":"eaaw1736","DOI":"10.1126\/scitranslmed.aaw1736","article-title":"Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain","volume":"11","author":"Burke","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.str.2026.08.013_bib26","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","article-title":"The JAK-STAT pathway at 30: Much learned, much more to do","volume":"185","author":"Philips","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.str.2026.08.013_bib27","doi-asserted-by":"crossref","first-page":"27261","DOI":"10.1074\/jbc.M115.672048","article-title":"Structural and functional characterization of the JH2 pseudokinase domain of JAK family tyrosine kinase 2 (TYK2)","volume":"290","author":"Min","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.str.2026.08.013_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112201","article-title":"Structural basis of Janus kinase trans-activation","volume":"42","author":"Caveney","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.str.2026.08.013_bib29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1126\/science.abn8933","article-title":"Structure of a Janus kinase cytokine receptor complex reveals the basis for dimeric activation","volume":"376","author":"Glassman","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.str.2026.08.013_bib30","doi-asserted-by":"crossref","first-page":"8025","DOI":"10.1073\/pnas.1401180111","article-title":"Structure of the pseudokinase-kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition","volume":"111","author":"Lupardus","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.str.2026.08.013_bib31","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/leu.2008.229","article-title":"JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science","volume":"22","author":"Kilpivaara","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.str.2026.08.013_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2025.130233","article-title":"Identification of small molecule activators targeting TYK2 pseudokinase domain","volume":"123","author":"Matsumoto","year":"2025","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.str.2026.08.013_bib33","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature19327","article-title":"Small molecule stabilization of the KSR inactive state antagonizes oncogenic Ras signalling","volume":"537","author":"Dhawan","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.str.2026.08.013_bib34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1021\/acs.biochem.0c00714","article-title":"Type II binders targeting the \u201cGLR-Out\u201d conformation of the pseudokinase STRAD\u03b1","volume":"60","author":"Smith","year":"2021","journal-title":"Biochemistry"},{"key":"10.1016\/j.str.2026.08.013_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aat7951","article-title":"Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cells","volume":"11","author":"Foulkes","year":"2018","journal-title":"Sci. Signal."},{"key":"10.1016\/j.str.2026.08.013_bib36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/bs.mie.2022.03.037","article-title":"Dynamics of protein kinases and pseudokinases by HDX-MS","volume":"667","author":"Sheetz","year":"2022","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.str.2026.08.013_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110291","article-title":"Targetable HER3 functions driving tumorigenic signaling in HER2-amplified cancers","volume":"38","author":"Campbell","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.str.2026.08.013_bib38","doi-asserted-by":"crossref","first-page":"21608","DOI":"10.1073\/pnas.0912101106","article-title":"Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3","volume":"106","author":"Jura","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.str.2026.08.013_bib39","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.1073\/pnas.1002753107","article-title":"ErbB3\/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation","volume":"107","author":"Shi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.str.2026.08.013_bib40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0014-4827(02)00101-5","article-title":"The deaf and the dumb: the biology of ErbB-2 and ErbB-3","volume":"284","author":"Citri","year":"2003","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.str.2026.08.013_bib41","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1042\/BCJ20210572","article-title":"The intracellular domains of the EphB6 and EphA10 receptor tyrosine pseudokinases function as dynamic signalling hubs","volume":"478","author":"Liang","year":"2021","journal-title":"Biochem. J."},{"key":"10.1016\/j.str.2026.08.013_bib42","doi-asserted-by":"crossref","first-page":"8211","DOI":"10.3390\/ijms22158211","article-title":"The EphB6 receptor: Kinase-dead but very much alive","volume":"22","author":"Strozen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.str.2026.08.013_bib43","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.cell.2009.04.025","article-title":"Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment","volume":"137","author":"Jura","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.str.2026.08.013_bib44","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nchembio.2171","article-title":"Overcoming resistance to HER2 inhibitors through state-specific kinase binding","volume":"12","author":"Novotny","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.str.2026.08.013_bib45","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/BJ20121513","article-title":"Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain","volume":"448","author":"Park","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.str.2026.08.013_bib46","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.molcel.2009.04.034","article-title":"The juxtamembrane region of the EGF receptor functions as an activation domain","volume":"34","author":"Red Brewer","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.str.2026.08.013_bib47","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.cell.2006.05.013","article-title":"An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor","volume":"125","author":"Zhang","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.str.2026.08.013_bib48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1042\/BST20130250","article-title":"HDX-MS takes centre stage at unravelling kinase dynamics","volume":"42","author":"Lorenzen","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.str.2026.08.013_bib49","first-page":"283","article-title":"Practical methods for deuterium exchange\/mass spectrometry","volume":"250","author":"Hoofnagle","year":"2004","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.str.2026.08.013_bib50","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev-anchem-062011-143113","article-title":"Analytical aspects of hydrogen exchange mass spectrometry","volume":"8","author":"Engen","year":"2015","journal-title":"Annu. Rev. Anal. Chem."},{"key":"10.1016\/j.str.2026.08.013_bib51","doi-asserted-by":"crossref","first-page":"12840","DOI":"10.1021\/acs.analchem.1c02155","article-title":"Probing universal protein dynamics using hydrogen-deuterium exchange mass spectrometry-derived residue-level Gibbs free energy","volume":"93","author":"Smit","year":"2021","journal-title":"Anal. Chem."},{"key":"10.1016\/j.str.2026.08.013_bib52","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1074\/jbc.M116.747485","article-title":"Biophysical evidence for intrinsic disorder in the C-terminal tails of the epidermal growth factor receptor (EGFR) and HER3 receptor tyrosine kinases","volume":"292","author":"Keppel","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.str.2026.08.013_bib53","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1063\/1.1730390","article-title":"Theory of the phase transition between helix and random coil in polypeptide chains","volume":"31","author":"Zimm","year":"1959","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.str.2026.08.013_bib54","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.32271","article-title":"Inhibitor-induced HER2-HER3 heterodimerisation promotes proliferation through a novel dimer interface","volume":"7","author":"Claus","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.str.2026.08.013_bib55","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/jps.22432","article-title":"The utility of hydrogen\/deuterium exchange mass spectrometry in biopharmaceutical comparability studies","volume":"100","author":"Houde","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.str.2026.08.013_bib56","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ccr.2013.04.012","article-title":"Oncogenic ERBB3 mutations in human cancers","volume":"23","author":"Jaiswal","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.str.2026.08.013_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2005786","article-title":"Structural analysis of the EGFR\/HER3 heterodimer reveals the molecular basis for activating HER3 mutations","volume":"7","author":"Littlefield","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.str.2026.08.013_bib58","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nbt.1990","article-title":"Comprehensive analysis of kinase inhibitor selectivity","volume":"29","author":"Davis","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.str.2026.08.013_bib59","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nchembio.1404","article-title":"A conserved water-mediated hydrogen bond network defines bosutinib's kinase selectivity","volume":"10","author":"Levinson","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.str.2026.08.013_bib60","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s42003-022-03517-3","article-title":"Empirical Bayes functional models for hydrogen deuterium exchange mass spectrometry","volume":"5","author":"Crook","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.str.2026.08.013_bib61","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.str.2025.11.017","article-title":"The role of kinase domain dimerization in EGFR activation","volume":"34","author":"Petrova","year":"2026","journal-title":"Structure"},{"key":"10.1016\/j.str.2026.08.013_bib62","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1042\/BCJ20200496","article-title":"A small molecule inhibitor of HER3: a proof-of-concept study","volume":"477","author":"Colomba","year":"2020","journal-title":"Biochem. J."},{"key":"10.1016\/j.str.2026.08.013_bib63","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1111\/febs.15246","article-title":"Cataloguing the dead: breathing new life into pseudokinase research","volume":"287","author":"Shrestha","year":"2020","journal-title":"FEBS J."},{"key":"10.1016\/j.str.2026.08.013_bib64","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.tibs.2024.10.002","article-title":"Eph receptor signaling complexes in the plasma membrane","volume":"49","author":"Pasquale","year":"2024","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.str.2026.08.013_bib65","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1038\/s41388-019-0931-2","article-title":"Eph receptor signalling: from catalytic to non-catalytic functions","volume":"38","author":"Liang","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.str.2026.08.013_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202300022","article-title":"Sticky, adaptable, and many-sided: SAM protein versatility in normal and pathological hematopoietic states","volume":"45","author":"Ray","year":"2023","journal-title":"Bioessays"},{"key":"10.1016\/j.str.2026.08.013_bib67","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.1038\/s41467-021-27343-z","article-title":"Regulation of the EphA2 receptor intracellular region by phosphomimetic negative charges in the kinase-SAM linker","volume":"12","author":"Lechtenberg","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.str.2026.08.013_bib68","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nbt.3374","article-title":"Comprehensive characterization of the Published Kinase Inhibitor Set","volume":"34","author":"Elkins","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.str.2026.08.013_bib69","doi-asserted-by":"crossref","first-page":"8009","DOI":"10.1158\/0008-5472.CAN-08-4889","article-title":"Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases","volume":"69","author":"Qian","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.str.2026.08.013_bib70","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.str.2026.08.013_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118274","article-title":"Allosteric inhibition of JAK2 with lysine-reactive compounds that bind the pseudokinase domain","volume":"302","author":"Primi","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.str.2026.08.013_bib72","doi-asserted-by":"crossref","first-page":"10959","DOI":"10.1021\/acs.jmedchem.3c00926","article-title":"Progress on the pharmacological targeting of Janus pseudokinases","volume":"66","author":"Henry","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.str.2026.08.013_bib73","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.sbi.2017.07.004","article-title":"Live and let die: insights into pseudoenzyme mechanisms from structure","volume":"47","author":"Murphy","year":"2017","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.str.2026.08.013_bib74","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tcb.2014.03.008","article-title":"Day of the dead: pseudokinases and pseudophosphatases in physiology and disease","volume":"24","author":"Reiterer","year":"2014","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.str.2026.08.013_bib75","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aat9797","article-title":"Emerging concepts in pseudoenzyme classification, evolution, and signaling","volume":"12","author":"Ribeiro","year":"2019","journal-title":"Sci. Signal."},{"key":"10.1016\/j.str.2026.08.013_bib76","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41586-025-09763-9","article-title":"Inhibitors supercharge kinase turnover through native proteolytic circuits","volume":"649","author":"Scholes","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.str.2026.08.013_bib77","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","article-title":"The PRIDE database at 20 years: 2025 update","volume":"53","author":"Perez-Riverol","year":"2025","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.str.2026.08.013_bib78","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1038\/s41467-022-34398-z","article-title":"Biochemical and structural basis for differential inhibitor sensitivity of EGFR with distinct exon 19 mutations","volume":"13","author":"van Alderwerelt van Rosenburgh","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.str.2026.08.013_bib79","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/bs.mie.2022.03.050","article-title":"Enabling pseudokinases as potential drug targets","volume":"667","author":"Preuss","year":"2022","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.str.2026.08.013_bib80","first-page":"2156","article-title":"Production of human beta interferon in insect cells infected with a baculovirus expression vector","volume":"3","author":"Smith","year":"1983","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.str.2026.08.013_bib81","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41592-019-0459-y","article-title":"Recommendations for performing, interpreting and reporting hydrogen deuterium exchange mass spectrometry (HDX-MS) experiments","volume":"16","author":"Masson","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.str.2026.08.013_bib82","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1007\/s13361-018-2056-1","article-title":"Optimized workflow for selecting peptides for HDX-MS data analyses","volume":"29","author":"S\u00f8rensen","year":"2018","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.str.2026.08.013_bib83","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/prot.340170110","article-title":"Primary structure effects on peptide group hydrogen exchange","volume":"17","author":"Bai","year":"1993","journal-title":"Proteins"},{"key":"10.1016\/j.str.2026.08.013_bib84","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1021\/j100830a521","article-title":"Use of glass electrodes to measure acidities in deuterium oxide","volume":"64","author":"Glasoe","year":"1960","journal-title":"J. Phys. Chem."}],"container-title":["Structure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969212626002601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969212626002601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:02:24Z","timestamp":1789848144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969212626002601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":84,"alternative-id":["S0969212626002601"],"URL":"https:\/\/doi.org\/10.1016\/j.str.2026.08.013","relation":{},"ISSN":["0969-2126"],"issn-type":[{"value":"0969-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulating pseudokinase conformation from the ATP-binding site","name":"articletitle","label":"Article Title"},{"value":"Structure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.str.2026.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}